TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in TCR2 Therapeutics Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
TCRR is no longer listed, so this page shows Q1 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 59
- −4 vs. Q4 2022
- Shares held
- 21.0M
- −208.4K (−1.0%) vs. Q4 2022
- Total value
- $31.5M
- +$10.3M (+48.7%) vs. Q4 2022
- New holders
- 7
- 12 more added
- Sold out
- 11
- 17 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 59 | $31.5M |
| Q4 2022 | 63 | $21.2M |
| Q3 2022 | 81 | $45.1M |
| Q2 2022 | 83 | $72.2M |
| Q1 2022 | 94 | $74.8M |
| Q4 2021 | 122 | $136.0M |
| Q3 2021 | 117 | $271.1M |
| Q2 2021 | 119 | $575.3M |
| Q1 2021 | 129 | $834.8M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 85 | $0 | 0.00% | 00.0% | Unchanged |
| Investors Research Corp | 15 | $23 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 35 | $53 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 61 | $92 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 140 | $210 | 0.00% | −545−79.6% | Reduced |
| UBS Group AG | 234 | $351 | 0.00% | +234 | New |
| Federation des caisses Desjardins du Quebec | 500 | $750 | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 700 | $1.05K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 800 | $1.20K | 0.00% | +800 | New |
| HighMark Wealth Management LLC | 840 | $1.26K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 1,444 | $2.00K | 0.00% | +1,444 | New |
| Advisor Group Holdings, Inc. | 1,801 | $2.70K | 0.00% | +451+33.4% | Added |
| Lindbrook Capital, LLC | 3,050 | $4.58K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 7,081 | $10.6K | 0.00% | −9,630−57.6% | Reduced |
| Tower Research Capital LLC (TRC) | 7,678 | $11.0K | 0.00% | +741+10.7% | Added |
| HRT Financial LP | 11,024 | $16.0K | 0.00% | −1,840−14.3% | Reduced |
| Goldman Sachs Group Inc | 10,765 | $16.1K | 0.00% | −956−8.2% | Reduced |
| Independent Financial Group, LLC | 12,075 | $18.1K | 0.00% | 00.0% | Unchanged |
| Newman Dignan & Sheerar, Inc. | 12,522 | $18.8K | 0.01% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 12,755 | $19.1K | 0.00% | 00.0% | Unchanged |
| HSBC Holdings PLC | 17,257 | $25.5K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 21,166 | $31.7K | 0.00% | −62,372−74.7% | Reduced |
| Charles Schwab Investment Management Inc | 22,638 | $34.0K | 0.00% | +22,638 | New |
| Commonwealth Equity Services, LLC | 24,973 | $37.0K | 0.00% | +2,500+11.1% | Added |
| Millennium Management LLC | 31,683 | $48.0K | 0.00% | −108,358−77.4% | Reduced |
| X-Square Capital, LLC | 31,720 | $48.0K | 0.03% | −199−0.6% | Reduced |
| Barclays PLC | 33,116 | $49.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 36,000 | $54.0K | 0.00% | −84,677−70.2% | Reduced |
| Gsa Capital Partners LLP | 37,452 | $56.0K | 0.01% | +37,452 | New |
| Oppenheimer & Co Inc | 37,950 | $56.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 40,688 | $61.0K | 0.00% | +14,004+52.5% | Added |
| Sagefield Capital LP | 43,900 | $65.8K | 0.02% | +43,900 | New |
| Price T Rowe Associates Inc | 48,900 | $74.0K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 57,279 | $85.9K | 0.00% | +12,129+26.9% | Added |
| Harbor Capital Advisors, Inc. | 67,642 | $101.5K | 0.03% | −588−0.9% | Reduced |
| Cornercap Investment Counsel Inc | 71,046 | $106.6K | 0.02% | +3,011+4.4% | Added |
| Northern Trust Corp | 93,933 | $140.9K | 0.00% | +7,441+8.6% | Added |
| Two Sigma Advisers, LP | 111,000 | $166.5K | 0.00% | −138,653−55.5% | Reduced |
| FMR LLC | 120,633 | $180.9K | 0.00% | +6,772+5.9% | Added |
| State Street Corp | 137,219 | $205.8K | 0.00% | +27,900+25.5% | Added |
| Morgan Stanley | 155,390 | $233.1K | 0.00% | +108,995+234.9% | Added |
| Dimensional Fund Advisors LP | 171,214 | $256.7K | 0.00% | −38,904−18.5% | Reduced |
| Bridgeway Capital Management, LLC | 181,810 | $272.7K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 315,377 | $473.1K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 383,486 | $575.2K | 0.00% | −89,998−19.0% | Reduced |
| Renaissance Technologies LLC | 444,800 | $667.0K | 0.00% | −248,486−35.8% | Reduced |
| JPMorgan Chase & Co | 524,184 | $787.0K | 0.00% | 00.0% | Unchanged |
| Long Focus Capital Management, LLC | 566,270 | $849.4K | 0.14% | +566,270 | New |
| Redmile Group, LLC | 658,336 | $987.5K | 0.04% | −73,043−10.0% | Reduced |
| Artal Group S.A. | 750,000 | $1.13M | 0.07% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 753,064 | $1.13M | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 789,911 | $1.18M | 0.00% | −962−0.1% | Reduced |
| Acadian Asset Management LLC | 812,459 | $1.22M | 0.01% | −62,394−7.1% | Reduced |
| Newtyn Management, LLC | 1,015,920 | $1.52M | 0.30% | −59,080−5.5% | Reduced |
| Vanguard Group Inc | 1,468,802 | $2.20M | 0.00% | +37,456+2.6% | Added |
| MPM Oncology Impact Management LP | 3,370,982 | $5.06M | 1.31% | 00.0% | Unchanged |
| Tang Capital Management LLC | 3,399,745 | $5.10M | 0.76% | +660,798+24.1% | Added |
| MPM Asset Management LLC | 4,050,865 | $6.08M | 2.53% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −233,876−100.0% | Sold out |
| Oasis Management Co Ltd. | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −120,389−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −74,297−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,295−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −32,803−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −31,992−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −26,600−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,204−100.0% | Sold out |
| Belpointe Asset Management LLC | 0 | $0 | 0.00% | −2,147−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |